Aziyo Biologics to Report Fourth Quarter and Full Year 2020 Financial Results on Monday, March 1, 2021
Aziyo Biologics, Inc. (Nasdaq: AZYO) will report its fourth quarter and full year earnings results on March 1, 2021, after market close. The management team will host a conference call to discuss the financial performance at 4:30 p.m. ET. Investors can access the details through the company's website and listen by dialing the provided numbers with the conference ID 4158569. Aziyo focuses on regenerative medicine, offering products for cardiovascular, orthopedic, and reconstructive specialties since its establishment in 2015.
- None.
- None.
SILVER SPRING, Md., Feb. 15, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that it plans to release its fourth quarter and full year earnings results after market close on Monday, March 1, 2021. Management will host a conference call to review the Company’s financial performance starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day. The conference call will be concurrently webcast.
The link to the webcast will be available on the Aziyo Biologics, Inc. website at www.aziyo.com under the investor relations section and will be archived for future reference. To listen to the conference call, please dial (833) 665-0667 (US/Canada) or (914) 987-7319 (International) and use the conference ID number 4158569 approximately ten minutes prior to the start time.
About Aziyo Biologics
Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties. For more information, visit www.Aziyo.com.
Media:
Courtney Guyer
Aziyo Biologics, Inc.
PR@aziyo.com
Investors:
Leigh Salvo
Gilmartin Group
investors@aziyo.com
FAQ
When will Aziyo Biologics release its earnings results?
What time is the Aziyo Biologics earnings call?
How can I listen to the Aziyo earnings call?